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ABSTRACT
　When nutritional supports are needed, enteral nutrition （EN） is recommended since it is more 
physiologic and effective compared with parental nutrition.  However, the efficacy and safety of 
EN remains unclear for patients who had complications after gastrectomy for gastric cancer.  In 
the current study, 4 patients took EN and 10 patients took total parental nutrition （TPN） due 
to complications after gastrectomy for gastric cancer from 2012 to 2014.  In the EN group, tube 
was placed through the nose into the small bowel using nasal endoscope and guide wire without 
any complications.  Total calorie given in EN group was significantly higher than that in TPN 
group （p=0.005）.  The rates of increase in serum concentration of total protein and albumin in 
EN group was higher than those in TPN group although there was not significant difference.  
Furthermore, postoperative length of hospital stay in EN group was shorter than that in TPN 
group without significant differences.  There is no complication attributed to EN while there are 
three catheter-related bloodstream infection in the TPN group.  Our results indicate that EN is 
effective and safe for patients who had complications after gastrectomy for gastric cancer. 
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経腸栄養群の治療前総蛋白値は5.5 ± 0.7 g/dLで
あったのに対して治療施行後は6.9 ± 0.7 g/dLで
あった．一方でTPN群では治療前が5.4 ± 1.1 g/
dLであったが，治療後は6.3 ± 0.5 g/dLであった．
さらに血清総蛋白上昇率では経鼻経腸栄養群25 
± 13%，TPN群22 ± 27%であった（表2,3）．
　血清アルブミン値に関しては，経鼻経腸栄養
群の治療前血清アルブミン値は2.5 ± 0.4 g/dLで
あったのに対して治療施行後は3.2 ± 0.5 g/dLで
あった．一方でTPN群では治療前が2.6 ± 0.8 g/
dLであったが，治療後は2.7 ± 0.5 g/dLであった．
さらに血清アルブミン上昇率では経鼻経腸栄養群





















人数　男/女 3/1 9/1 0.506
年齢（歳） 74±7.5 70.8±10 0.578











　Ⅲ+ Ⅳ 0 2
再手術例 0 4 0.251
合併症発症日（術後） 5.3±1.7 6.2±2.8 0.547
既往症
　高血圧 4 5 0.221
　糖尿病 1 2 ＞0.999






























































抗生剤使用期間（日） 18±13.3 19.4±9.9 0.84
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